سعر هيرمبرو 5مجم 20 قرص 2022

Hermpro 5 mg escitalopram film-coated tablets, pack of 20 (2 strips), marketed in Egypt by Sabaa > Sovalue Pharma; selective serotonin reuptake inhibitor antidepressant.

• Major depressive disorder in adults and pediatric patients 12 years and older.Population: Adults and adolescents >=12 yearsDailyMed (U.S. National Library of Medicine)
• Generalized anxiety disorder in adults and pediatric patients 7 years and older.Population: Adults and children >=7 yearsDailyMed (U.S. National Library of Medicine)

• Most common (>=5% and at least twice placebo): insomnia, ejaculation disorder (mainly delayed ejaculation), nausea, increased sweating, fatigue, somnolence, decreased libido and anorgasmia.International label, equivalent formulation · DailyMed (U.S. National Library of Medicine)

• Use with MAOIs or within 14 days of stopping escitalopram, or within 14 days of stopping an MAOI intended to treat psychiatric disorders; do not start in patients being treated with linezolid or intravenous methylene blue (serotonin syndrome risk).International label, equivalent formulation · DailyMed (U.S. National Library of Medicine)
• Concomitant pimozide.International label, equivalent formulation · DailyMed (U.S. National Library of Medicine)
• Hypersensitivity to escitalopram, citalopram or any inactive ingredient.International label, equivalent formulation · DailyMed (U.S. National Library of Medicine)

• Boxed warning: antidepressants increased the risk of suicidal thoughts and behaviours in pediatric and young adult patients in short-term studies; closely monitor all treated patients for clinical worsening and emergence of suicidal thoughts and behaviours.International label, equivalent formulation · DailyMed (U.S. National Library of Medicine)
• Serotonin syndrome, with increased risk when combined with other serotonergic agents; discontinue and give supportive treatment if it occurs.International label, equivalent formulation · DailyMed (U.S. National Library of Medicine)
• Discontinuation syndrome: taper the dose gradually; seizures (use with caution in patients with seizure history); activation of mania/hypomania (screen for bipolar disorder before starting).International label, equivalent formulation · DailyMed (U.S. National Library of Medicine)

• Monoamine oxidase inhibitors (including linezolid, IV methylene blue)Increased risk of serotonin syndrome; combination contraindicated.DailyMed (U.S. National Library of Medicine)
• PimozideRacemic citalopram increased pimozide concentrations with possible QT prolongation; combination contraindicated.DailyMed (U.S. National Library of Medicine)
• Other serotonergic drugs (SSRIs, SNRIs, triptans, tricyclics, opioids, lithium, buspirone, amphetamines, tryptophan, St John's wort)Increased risk of serotonin syndrome; monitor, especially at initiation and dose increases.DailyMed (U.S. National Library of Medicine)

• Published data have not established an increased risk of major birth defects or miscarriage; SSRI exposure (particularly in the month before delivery) has been associated with a less than 2-fold increased risk of postpartum haemorrhage; risks of persistent pulmonary hypertension of the newborn and poor neonatal adaptation; untreated depression also carries risks.International label, equivalent formulation · DailyMed (U.S. National Library of Medicine)
• Escitalopram and desmethylescitalopram are present in human milk; excessive sedation, restlessness, agitation, poor feeding and poor weight gain have been reported in exposed infants, who should be monitored.International label, equivalent formulation · DailyMed (U.S. National Library of Medicine)

• Escitalopram: The S-enantiomer of citalopram; its antidepressant action is presumed to result from potentiation of CNS serotonergic activity through inhibition of neuronal serotonin (5-HT) reuptake.